BMD4503-1

BMD4503-1 is a quinoxaline derivative. BMD4503-1 can inhibit the LRP5/6-Sclerostin interaction and regulate the Wnt signaling pathway.

For research use only. We do not sell to patients.

  • CAS No.: 301357-76-6
  • Formula: C22H19N5O3S
  • Molecular Weight:433.48
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All Wnt Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00